40 research outputs found

    Studies on the clinical significance of nonesterified and total cholesterol in urine

    Get PDF
    Gas-liquid chromatographic determinations of nonesterified and total urinary cholesterol were performed in 137 normals, 264 patients with various internal diseases without evidence of neoplasias or diseases of the kidney or urinary tract, 497 patients with malignancies and 236 patients with diseases of the kidney, urinary tract infections or prostatic adenoma with residual urine. A normal range (mean±2 SD) of 0.2–2.2 mg/24 hours nonesterified cholesterol (NEC) and of 0.3–3.0 mg/24 hours total cholesterol (TC) was calculated. Values of urinary cholesterol excretion were independent of age and sex and did not correlate with cholesterol levels in plasma. Patients with various internal diseases, without evidence of neoplasias nor diseases of the kidney or obstruction of the urinary tract, showed normal urinary cholesterol excretions, as did patients with infections of the urinary tract. However, elevated urinary cholesterol was found in patients with diseases of the kidney or urinary tract obstruction (prostatic adenoma with residual urine), malignant diseases of the urogenital tract and metastasing carcinoma of the breast. In patients with other malignant diseases urinary cholesterol was usually normal. Lesions of the urothelial cell membranes are considered to be the most likely cause of urinary cholesterol hyperexcretion. The clinical value of urinary cholesterol determinations as a possible screening test for urogenital carcinomas in unselected populations is limited by lacking specificity, expensive methodology and low prevalence of the mentioned carcinomas, although elevated urinary cholesterol excretions have been observed in early clinical stages of urogenital cancers

    Cultivating trust in technology-mediated sustainable agricultural research

    Get PDF
    We formed the Precision Sustainable Agriculture (PSA) team to conduct interdisciplinary research and technology development to improve adoption and practice of knowledge-intensive sustainable agricultural practices such as cover cropping. In this paper, we share our approach to cultivating trust among diverse stakeholders (researchers, farmers, extensionists, agricultural and information specialists, private and public entities) vested in agricultural data collection, management, and use. Our trust framework describes how we aim to be trusted with data (through preserving privacy and increasing stakeholder agency) and trusted in the process (through practicing transparency and accountability). It is operationalized through a series of social and technical infrastructures. Our project governance, stakeholder engagement tools and activities, and technology development methods aim to promote transparency and accountability in our process. We use a maturity model to govern data acquisition to ensure that only robust, privacy-preserving technologies are deployed on our partner farms and describe evolving mechanisms for handling data with varying sensitivity. Finally, we share preliminary work aimed at anticipating data use, and identify challenges on the horizon for cultivating trust in agricultural technologies and data-driven agriculture.This article is published as Raturi, Ankita, Jennifer J. Thompson, Victoria Ackroyd, Carlene A. Chase, Brian W. Davis, Robert Myers, Aurelie Poncet et al. "Cultivating trust in technology‐mediated sustainable agricultural research." Agronomy Journal (2021). doi:10.1002/agj2.20974. Works produced by employees of the U.S. Government as part of their official duties are not copyrighted within the U.S. The content of this document is not copyrighted
    corecore